Evidence map›Paper›PMID 22114968›Full record

ReviewExpert review of anti-infective therapy2011

Mannose-binding lectin and the balance between immune protection and complication.

Kazue Takahashi

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of anti-infective therapy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Polymorphisms in theFrontiers in immunology · 2023
    Article
  6. Review
  7. Activity of Mannose-Binding Lectin on Bacterial-Infected Chickens-A Review.Animals : an open access journal from MDPI · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Fibrinogen-specific antibody induces abdominal aortic aneurysm in mice through complement lectin pathway activation.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Kazue TakahashiDepartment of Pediatrics, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, GRJ1402, Boston, MA 02114, USA. ktakahashi1@partners.org
Massachusetts General Hospital · US

Funding

Development of novel immunotherapy for influenza virus infectionU01AI074503 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI TAKAHASHI, KAZUE · 2007 to 2011
$4.7M
Innate Immunity in the Clearance of Influenza A Virus Infected Apoptotic CellsR21AI077081 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI TAKAHASHI, KAZUE · 2007 to 2008
$475k
NIAID NIH HHS R21 AI077081NIAID NIH HHS U01 AI074503
6 · The paper itself

Abstract

The innate immune system is evolutionarily ancient and biologically primitive. Historically, it was first identified as an element of the immune system that provides the first-line response to pathogens, and increasingly it is recognized for its central housekeeping role and its essential functions in tissue homeostasis, including coagulation and inflammation, among others. A pivotal link between the innate immune system and other functions is mannose-binding lectin (MBL), a pattern recognition molecule. Multiple studies have demonstrated that MBL deficiency increases susceptibility to infection, and the mechanisms associated with this susceptibility to infection include reduced opsonophagocytic killing and reduced activation of the lectin complement pathway. Results from our laboratory have demonstrated that MBL and MBL-associated serine protease (MASP)-1/3 together mediate coagulation factor-like activities, including thrombin-like activity. MBL and/or MASP-1/3-deficient hosts demonstrate in vivo evidence that MBL and MASP-1/3 are involved with hemostasis following injury. Staphylococcus aureus-infected MBL null mice developed disseminated intravascular coagulation, which was associated with elevated blood IL-6 levels (but not TNF-α) and systemic inflammatory responses. Infected MBL null mice also develop liver injury. These findings suggest that MBL deficiency may manifest as disseminated intravascular coagulation and organ failure with infection. Beginning from these observations, this review focuses on the interaction of innate immunity and other homeostatic systems, the derangement of which may lead to complications in infection and other inflammatory states.

Indexed as

Immunity, InnateAnimalsBlood CoagulationComplement ActivationComplement Pathway, Mannose-Binding LectinDisease SusceptibilityDisseminated Intravascular CoagulationHumansInflammationInterleukin-6Mannose-Binding Protein-Associated Serine ProteasesMiceMice, KnockoutOpsonin ProteinsPhagocytosisStaphylococcal InfectionsInterleukin-6Mannose-Binding Protein-Associated Serine ProteasesMASP1 protein, humanMASP2 protein, humanOpsonin Proteins

Identifiers

PMID22114968
PMCPMC3259613
OpenAlexW2164148080

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.